Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2023 Nov 3;129(12):2034. doi: 10.1038/s41416-023-02481-x

Correction: Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancer

Masayuki Shirasawa 1,2,3, Tatsuya Yoshida 1,4,✉, Kouya Shiraishi 2, Naoko Goto 1, Shigehiro Yagishita 4, Tatsuya Imabayashi 5, Yuji Matsumoto 1,5, Ken Masuda 1, Yuki Shinno 1, Yusuke Okuma 1, Yasushi Goto 1, Hidehito Horinouchi 1, Masaya Yotsukura 6, Yukihiro Yoshida 6, Kazuo Nakagawa 6, Katsuhiko Naoki 3, Takaaki Tsuchida 5, Ryuji Hamamoto 7, Noboru Yamamoto 1,4, Noriko Motoi 2,8,9, Takashi Kohno 2, Shun-ichi Watanabe 6, Yuichiro Ohe 1
PMCID: PMC10703798  PMID: 37923915

Correction to: British Journal of Cancer 10.1038/s41416-023-02427-3, published online 20 September 2023

In the caption of fig 3d is typo. The sentence “The top box indicates the DLL3 expression (z score). Heatmaps: expression of 18-gene-γ-related T-cell gene expression profiles (T-cell GEPs) and 13 chemokine markers of high and low DLL3 expression tumors are shown.” should read “The top box indicates the DLL3 expression (z score). Heatmaps: expression of 18-gene-γ-related T-cell gene expression profiles (T-cell GEPs) and 12 chemokine markers of high and low DLL3 expression tumors are shown.”

The original article has been corrected.

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES